100 results
Page 3 of 5
10-K/A
49nqq5xq93
29 Apr 22
Annual report (amended)
4:43pm
DEFC14A
3nuqg9 ttmvwn
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
shaj4nhalc7t7
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PREC14A
anlehyjw
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
ocurcf cs9qjj
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
dx6fyj51i d8vljt
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
EX-10.11
xn9m08x
31 Mar 22
Annual report
8:18am
10-K
EX-23.1
42ei 0pqp2b2
31 Mar 22
Annual report
8:18am
10-K
EX-10.5
fwtot9evsfbsxljrqu35
31 Mar 22
Annual report
8:18am
10-K
cjv3wf 2ge0bt128
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
5uu9mr 0b
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
EX-99.1
z076 mqrdu98p2gvf38
21 Mar 22
Departure of Directors or Certain Officers
6:32am
8-K/A
EX-99.1
6ybwe7l46pj8d g8
21 Mar 22
Departure of Directors or Certain Officers
6:30am
8-K
EX-99.1
p7znt1d4 bukl
13 Jan 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
ei56qvi g7b
15 Nov 21
Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results
8:08am
10-Q
EX-10.5
lxv08gv
20 Sep 21
Quarterly report
4:17pm